IP Verse

Further Novel Forms Of Interfering Rna Molecules - EP1857547

The patent EP1857547 was granted to Atugen on Dec 2, 2020. The application was originally filed on Aug 5, 2003 under application number EP06027129A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP1857547

ATUGEN
Application Number
EP06027129A
Filing Date
Aug 5, 2003
Status
Patent Maintained As Amended
Oct 30, 2020
Grant Date
Dec 2, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SANOFIOct 17, 2018MATHYS & SQUIREWITHDRAWN
THE MEDICINES UKOct 16, 2018BIRD & BIRDWITHDRAWN
ALNYLAM PHARMACEUTICALSAug 17, 2018POTTER CLARKSONWITHDRAWN

Patent Citations (35) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONCA2432350
OPPOSITIONEP0653439
OPPOSITIONEP1144623
OPPOSITIONEP1214945
OPPOSITIONEP1550719
OPPOSITIONEP2258847
OPPOSITIONUS2003190635
OPPOSITIONUS38678202P
OPPOSITIONUS5811533
OPPOSITIONUS6107094
OPPOSITIONUS6239272
OPPOSITIONUS6348312
OPPOSITIONUS7452987
OPPOSITIONUS8114851
OPPOSITIONWO0044895
OPPOSITIONWO02055693
OPPOSITIONWO02097114
OPPOSITIONWO0216620
OPPOSITIONWO0244321
OPPOSITIONWO03064621
OPPOSITIONWO03070895
OPPOSITIONWO03070912
OPPOSITIONWO03070918
OPPOSITIONWO9207065
OPPOSITIONWO9401550
OPPOSITIONWO9618736
OPPOSITIONWO9746570
OPPOSITIONWO9954459
OPPOSITIONWO9955857
SEARCHWO0044895
SEARCHWO02055693
SEARCHWO0244321
SEARCHWO03070912
SEARCHWO9513834
SEARCHWO9741141

Non-Patent Literature (NPL) Citations (58) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "European Medicines Agency (EMA) Grants Alnylam Accelerated Assessment of Patisiran for Patients with Hereditary ATTR (hATTR) Amyloidosis", Alnylam press release, (20171113), URL: https://www.businesswire.com/news/home/20171113005411/en/European-Medicines-Agency-EMA-Grants-Alnylam-Accelerated, XP055524869-
OPPOSITION- CUMMINS et al., "Characterization of fully 2'-modified oligoribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity", Nucleic Acids Res., (19950000), vol. 23, no. 11, pages 2019 - 2024, XP002492384-
OPPOSITION- Dictionary of Scientific and Technical Terms, page 1457-
OPPOSITION- FIEDRICH, "Sequenzanalyse", FIEDRICH, Fiedrich Lottspeich; Haralabos Zorbas, Bioanalytik, Spektrum Akademischer Verlag, page 785, XP055444098-
OPPOSITION- Hackh's Chemical Dictionary- Extract-
OPPOSITION- INOUE H. et al., "Synthesis and hybridization studies on two complementary nona(2'-o-methyl)ribonucleotides", Nucleic Acids Res, (19870000), vol. 15, pages 6131 - 6148, XP002000169-
OPPOSITION- INOUE H. et al., "Synthesis and hybridization studies on two complementary nona(2'-o-methyl)ribonucleotides", NUCLEIC ACIDS RESEARCH, (19870000), vol. 15, pages 6131 - 6148, XP000570336-
OPPOSITION- Lottspeich, "Sequenzanalyse", Bioanalytik, (19980000), page 785, XP055444098-
OPPOSITION- MANOHARAN M., "2'-Carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation", Biochimica et Biopohysica Acta, (19990000), vol. 1489, pages 117 - 130, XP000979474-
OPPOSITION- MCGRAW-HILL, Dictionary of Scientific and Technical Terms, page 1457-
OPPOSITION- "Muster (Struktur)", Wikipedia, (20080924), URL: https://de.wikipedia.org/wiki/Muster_%28Struktur%29, XP055444070-
OPPOSITION- "Muster (Struktur)", Wikipedia, URL: https://de.wikipedia.org/wiki/Muster_%28Struktur%29, XP055444070-
OPPOSITION- Natasha Loder, "A new era of medicine will come into view", The EconomistTM, (20170000), pages 1 - 4, XP055524873-
OPPOSITION- "pattern", Oxford English Dictionary. 5th ed,, (19330000), page 2123, XP055444074-
OPPOSITION- "Pattern", Shorter Oxford English Dictionary Fifth edition, (20030000), vol. 2, page 2123, XP055444074-
OPPOSITION- "Sequence motif", Wikipedia entry, (20090227), XP055444076-
OPPOSITION- "Sequence motif", Wikipedia, the free encyclopedia, (20090227), pages 1 - 6, XP055444076-
OPPOSITION- LUBINI et al., "Stabilizing effects of the RNA 2'-substituent: crystal structure of an oligodeoxynucleotide duplex containing 2'-O-methylated adenosines", Chemistry & Biology, (19940000), vol. 1, pages 39 - 45, XP023882309
OPPOSITION- CHOUNG et al., "Chemical modification of siRNAs to improve serum stability without loss of efficacy", Biochem Biophys Res Comm, (20060000), vol. 342, no. 3, pages 919 - 927, XP024923668
OPPOSITION- CHOUNG et al., "Chemical modification of siRNAs to improve serum stability without loss of efficacy", Biochem Biophys Res Comm, (20060000), vol. 342, pages 919 - 927, XP024923668
OPPOSITION- MANOHARAN, "RNA interference and chemically modified small interfering RNAs", Curr Opin Chem Biol, (20040000), vol. 8, no. 6, pages 570 - 579, XP004649493
OPPOSITION- MARTINEZ J1 et al., "Single-stranded antisense siRNAs guide target RNA", Cell, (20020906), vol. 110, no. 5, pages 563 - 574, XP002257819
OPPOSITION- MANOHARAN M., "2'-Carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation", BIOCHIMICA ET BIOPHYSICA ACTA, (19990000), vol. 1489, no. 1, pages 117 - 130, XP004275527
OPPOSITION- PARRISH S. et al., "Functional anatomy of a dsRNA trigger: Differential requirement for the two trigger strands in RNA interference", MOLECULAR CELL, (20000000), vol. 6, no. 5, pages 1077 - 1087, XP002226298
OPPOSITION- SCHWARZ, DS et al., "Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways", Mol Cell, (20020900), vol. 10, pages 537 - 548, XP002257820
OPPOSITION- YA-LIN CHIU et al., "RNAi in Human Cells: Basic Structural and Functional Features of Small Interfering RNA", Molecular Cell,, (20020900), vol. 10, pages 549 - 561, XP002978510
OPPOSITION- LESNIK et al., "Oligodeoxynucleotides containing 2'-O-modified adenosine: Synthesis and effects on stability of DNA:RNA duplexes", Biochemistry, (19930000), vol. 32, pages 7832 - 7838, XP002913880
OPPOSITION- BEVILACQUA P.C. et al., "Minor groove recognition of double stranded RNA by the double stranded RNA binding domain from the RNA activated protein kinase PKR", BIOCHEMISTRY, (19960000), vol. 35, pages 9983 - 9994, XP002091877
OPPOSITION- BUTORA et al., "Nucleoside Optimization for RNAi: A High-Throughput Platform", J. Am. Chem. Soc., (20111026), vol. 133, no. 42, pages 16766 - 16769, XP055057703
OPPOSITION- BUTORA et al., "Nucleoside Optimization for RNAi: A High-Throughput Platform", J. Am. Chem. Soc., (20111026), vol. 133, pages 16766 - 16769, XP055057703
OPPOSITION- FIRE A. et al., "Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans", Nature, (19980000), vol. 391, pages 806 - 811, XP002095876
OPPOSITION- FIRE A. et al., "Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans", NATURE, (19980000), vol. 391, pages 806 - 811, XP002095876
OPPOSITION- KENSKI, "siRNA-optimized Modifications for Enhanced In Vivo Activity", Molecular Therapy-Nucleic Acids, (20120000), vol. 1, page e5, XP055159208
OPPOSITION- WU H. et al., "Identification and partial purification of human double strand RNase activity. A novel terminating mechanism for oligoribonucleotide antisense drugs", JOURNAL OF BIOLOGICAL CHEMISTRY, (19980000), vol. 273, no. 5, pages 2532 - 2542, XP002234692
OPPOSITION- WU H. et al., "Identification and partial purification of human double strand RNase activity. A novel terminating mechanism for oligoribonucleotide antisense drugs", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (19980000), vol. 273, no. 5, pages 2532 - 2542, XP002234692
OPPOSITION- HARBORTH, J et al., "Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing", Antisense Nucleic Acid Drug Dev, (20030400), vol. 13, no. 2, pages 83 - 105, XP002284355
OPPOSITION- COLLINGWOOD et al., "Chemical Modification Patterns Compatible with High Potency Dicer-Substrate Small Interfering RNAs", Oligonucleotides, (20080000), vol. 18, no. 2, pages 187 - 200, XP002623649
OPPOSITION- BEHLKE, "Chemical modification of siRNAs for in vivo use", Oligonucleotides, (20080000), vol. 18, pages 305 - 320, XP002558504
OPPOSITION- CONKLIN et al., "Association of nucleotide patterns with gene function classes: application to human 3' untranslated sequences", Bioinformatics Discovery Note, (20020000), vol. 18, pages 182 - 189, XP055444079
OPPOSITION- CONKLIN et al., "Association of nucleotide patterns with gene function classes: application to human 3' untranslated sequences", Bioinformatics Discovery Note, (20020100), vol. 18, pages 182 - 189, XP055444079
OPPOSITION- ELBASHIR S.M. et al., "Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate", EMBO JOURNAL, (20010000), vol. 20, no. 23, pages 6877 - 6888, XP002225998
OPPOSITION- ELBASHIR S.M. et al., "Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate", EMBO JOURNAL, (20011203), vol. 20, no. 23, pages 6877 - 6888, XP002304126
OPPOSITION- PARRISH S. et al., "Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate", MOLECULAR CELL, (20000000), vol. 6, pages 1077 - 1087, XP002304126
OPPOSITION- MAJLESSI et al., "Advantages of 2'-O-methyl oligoribonucleotide probes for detecting RNA targets", Nucleic Acids Res., (19980000), vol. 26, pages 2224 - 2229, XP002241700
OPPOSITION- AMARZGUIOUI, M et al., "Tolerance for mutations and chemical modifications in a siRNA", Nucleic Acids Res, (20030100), vol. 31, pages 589 - 595, XP002281440
OPPOSITION- AMARZGUIOUI, M. et al., "Tolerance for mutations and chemical modifications in a siRNA", Nucleic Acids Res, (20030115), vol. 31, no. 2, pages 589 - 595, XP002281440
OPPOSITION- CZAUDERNA F. et al., "Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells", Nucleic Acids Res, (20030601), vol. 31, no. 11, pages 2705 - 2716, XP002270732
OPPOSITION- CZAUDERNA F. et al., "Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells", NUCLEIC ACIDS RESEARCH, (20030000), vol. 31, no. 11, pages 2705 - 2716, XP002270732
OPPOSITION- KOLLER et al., "Competition for RISC binding predicts in vitro potency of siRNA", Nucl Acid Res, (20060000), vol. 34, no. 16, pages 4467 - 4476, XP002412029
OPPOSITION- KOLLER et al., "Competition for RISC binding predicts in vitro potency of siRNA", Nucl Acid Res, (20060831), vol. 34, no. 16, pages 4467 - 4476, XP002412029
OPPOSITION- ADAMS et al., "Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy", BMC Neurology, (20170000), vol. 17, XP055524855
OPPOSITION- COOK P.D., "2 MEDICINAL CHEMISTRY OF ANTISENSE OLIGONUCLEOTIDES", ANTISENSE DRUG TECHNOLOGY: Principles Strategies and Applications, New York, pages 29 - 56, XP002994162
OPPOSITION- COOK P.D., "Medicinal Chemistry of Antisense Oligonucleotides", Antisense Drug Technology, Principles, Strategies and Applications, New York, (20010000), pages 29 - 56, XP002994162
OPPOSITION- CHIU YA-LIN et al., "siRNA function in RNAi: a chemical modification analysis", RNA, (20030000), vol. 9, pages 1034 - 1048, XP002336178
OPPOSITION- CAPODICI et al., "Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference", The Journal of Immunology, (20021101), vol. 169, pages 5196 - 5201, XP002988100
SEARCH- PARRISH S ET AL, "Functional anatomy of a dsRNA trigger: Differential requirement for the two trigger strands in RNA interference", MOLECULAR CELL, (200011), vol. 6, no. 5, ISSN 1097-2765, pages 1077 - 1087, XP002226298 [X] 1-5,9-13,24,30,40,42,44 * page 1081, column R; figure 5 * * page 1084, column L, paragraph 2 * [Y] 1-44
SEARCH- STERNBERGER M ET AL, "GeneBlocs are powerful tools to study and delineate signal transduction processes that regulate cell growth and transformation", ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, (200206), vol. 12, no. 3, ISSN 1087-2906, pages 131 - 143, XP002226299 [AD] 1-44 * the whole document *
SEARCH- CZAUDERNA FRANK ET AL, "Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells.", NUCLEIC ACIDS RESEARCH, (20030601), vol. 31, no. 11, ISSN 0305-1048, pages 2705 - 2716, XP002270732 [XP] 1-30,40,42-44 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents